F-18 FDG Positron Emission Tomography Demonstration of Pulmonary Carcinoid
- 1 June 2004
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 29 (6), 370-371
- https://doi.org/10.1097/01.rlu.0000127093.88921.fb
Abstract
Although experience with positron emission tomography (PET) using F-18 FDG for imaging pulmonary carcinoid tumors is limited to date, uptake is usually much lower than expected for lung carcinoma or metastatic adenocarcinoma, or it is not present at all. On a routine chest radiograph, a 74-year-old woman with intraductal breast carcinoma was discovered to have a new right middle lobe nodule. The nodule was intensely hypermetabolic on F-18 FDG PET and was therefore believed to be a metastasis in this nonsmoking patient; however, at wedge resection, the nodule proved to be a primary pulmonary typical carcinoid tumor.Keywords
This publication has 6 references indexed in Scilit:
- The Role of PET in Localization of Neuroendocrine and Adrenocortical TumorsAnnals of the New York Academy of Sciences, 2002
- Recent advances in carcinoid pathogenesis, diagnosis and managementSurgical Oncology, 2000
- Neuroendocrine Tumor Imaging: Can 18F‐Fluorodeoxyglucose Positron Emission Tomography Detect Tumors with Poor Prognosis and Aggressive Behavior?World Journal of Surgery, 1998
- Evaluation of primary pulmonary carcinoid tumors using FDG PET.American Journal of Roentgenology, 1998
- Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucoseCancer, 1993
- Positron Emission Tomography (PET) in Neuroendocrine Gastrointestinal TumorsActa Oncologica, 1993